Surfactant Protein D in Patients with Chronic Pulmonary Aspergillosis

ConclusionsWith pulsed echinocandin therapy, azole ‐intolerant or pan‐resistant CPA patients have similar mortality rates to azole‐naïve CPA patients. Pulsed echinocandin therapy may present a strategy to stabilize CPA in patients with pan resistance or intolerance to, azole therapy.

Source: The Clinical Respiratory JournalCategory: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLE Source Type: research

Source link